Old drugs, new hope? early trial combines metformin, digoxin, and simvastatin for advanced cancers
NCT ID NCT03889795
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial is testing whether a combination of three widely used drugs—metformin (for diabetes), digoxin (for heart conditions), and simvastatin (for cholesterol)—can be safely given to people with advanced pancreatic cancer or other solid tumors that have stopped responding to standard treatments. The main goal is to find the safest dose and watch for side effects. Only 15 participants are enrolled, so this is a first step to see if further study is warranted.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Metformin, digoxin, and simvastatin (oral pills)
- What this could lead to
- If it works, this could point toward a new, low-cost combination approach for advanced cancers that have stopped responding to standard treatments.
- What could go wrong
- This is a very early (Phase 1) trial with only 15 people, so it is mainly checking safety and dosing. It is not designed to prove the drugs shrink tumors or extend life, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Toledo, Eleanor N. Dana Cancer Center
Toledo, Ohio, 43614, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your own immune cells beat advanced cancer?
- Tumor DNA mapping may unlock personalized cancer therapies
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a protein calm the immune System's overreaction to cancer treatment?
- Can a new drug shrink Hard-to-Treat tumors?
- Can a Custom-Made immune cell vaccine turn the tide against solid tumors?